FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to amide of δ-amino-γ-hydroxy-ω-arylalcane acid of formula 
and its pharmaceutically acceptable salts. Also described are pharmaceutical compositions, which include said compounds, and application of said compounds for preparation of medication, intended for treatment of pathological states, associated with renin activity, in particular for treatment of hypertension.
EFFECT: obtaining pharmaceutically acceptable salts, which possess rennin-inhibiting ability.
21 cl, 161 ex
| Title | Year | Author | Number |
|---|---|---|---|
| (-AMINO-(-HYDROXY-(-ARYLALKANOIC AMIDES AND USE THEREOF AS RENIN INHIBITORS | 2004 |
|
RU2425027C2 |
| METHODS FOR INCREASING BIOLOGICAL AVAILABILITY OF RENIN INHIBITOR | 2005 |
|
RU2404758C2 |
| OPENING CYCLES OF LACTONES AND LACTAMS | 2010 |
|
RU2550691C2 |
| RENNIN INHIBITOR SYNTHESIS WITH USING CYCLOADDITION REACTION | 2006 |
|
RU2423348C2 |
| NEW CONJUGATES BINDING COMPOUND - ACTIVE COMPOUND (ADC) AND USE THEREOF | 2012 |
|
RU2610336C2 |
| METHOD OF OBTAINING RENIN INHIBITORS | 2006 |
|
RU2418785C2 |
| ALTERNATIVE METHODS FOR SYNTHESIS OF RENIN INHIBITORS AND INTERMEDIATE COMPOUNDS THEREOF | 2005 |
|
RU2411230C2 |
| SECONDARY AMINES AS RENIN INHIBITORS | 2007 |
|
RU2425032C2 |
| CALICHEAMICIN DERIVATIVES AND THEIR ANTIBODY-DRUG CONJUGATES | 2018 |
|
RU2732568C1 |
| BRIDGED SPIRO[2,4]HEPTANE DERIVATIVES AS ALX AND/OR FPRL2 RECEPTOR AGONISTS | 2010 |
|
RU2540274C2 |
